Sensus Healthcare Inc
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
| (a) | Sales of Unregistered Securities |
|---|
There were no unregistered sales of securities during the three months ended March 31, 2025.
| (b) | Use of Proceeds from the Sale of Registered Securities |
|---|
None.
| (c) | Purchases of Equity Securities by the Registrant and Affiliated Purchasers. |
|---|
In August 2023, the Company’s Board of Directors authorized a program to purchase up to $3,000,000 of shares of the Company’s common stock. Purchases may be made from time to time in a variety of methods, including open market purchases, depending upon market conditions, including the market price of the common stock, and other factors. The program (i) does not obligate the Company to acquire any particular amount of its common stock, (ii) has no time limit, and (iii) may be modified, suspended, or discontinued at any time at the Company’s discretion.
The following table contains information about all purchases made during the three months ended March 31, 2025 by, or on behalf of, us and any affiliated purchaser (as defined in Rule 10b-18(a)(3) under the Exchange Act) of shares or other units of any class of our equity securities that is registered pursuant to Section 12 of the Exchange Act.
| Total number of shares repurchased | Average price paid per share | Total number of shares (or units) purchased as part of publicly announced plans or programs | Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs | |
|---|---|---|---|---|
| January 1, 2025 to January 31, 2025 | — | $— | — | $2,972,812 |
| February 1, 2025 to February 28, 2025 | 50,360 | $5.90 | 50,360 | $2,672,816 |
| March 1, 2025 to March 31, 2025 | — | $— | — | $2,672,816 |
| Total | 50,360 | $5.90 | 50,360 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.